NEMO/ATM/IKKα复合体:在结直肠癌的进展和治疗中起着关键作用
1Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
Science signaling
|March 11, 2025
概括
调控子单元NEMO有助于大肠直肠癌细胞中的DNA修复. 它引导ATM/IKKα复合体到DNA损伤部位,改善修复和化疗耐药性.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- DNA 修复机制的修复机制
背景情况:
- 激酶ATM对于DNA修复至关重要.
- 激酶IKKα酸化ATM,增强DNA的修复.
- 目前尚不完全了解NEMO在将ATM/IKKα向DNA损伤部位方面的作用.
研究的目的:
- 调查NEMO在ATM/IKKα综合体中的作用.
- 确定NEMO如何影响结直肠癌细胞中的DNA修复.
- 探索对化疗耐药性的影响.
主要方法:
- 结直肠癌细胞的细胞培养.
- 免疫光显微镜可视化蛋白质定位.
- 西方斑点测试用于评估蛋白质酸化.
- 检测DNA损伤以量化修复效率.
- 化疗敏感性测定. 化疗敏感性测定.
主要成果:
- NEMO将ATM/IKKα复合体针对DNA损伤的部位.
- 这种准增强了ATM的DNA修复活动.
- ATM/IKKα/NEMO复合物促进结直肠癌细胞对化疗的耐药性.
结论:
- 通过ATM/IKKα复合体,NEMO在促进DNA修复方面发挥着至关重要的作用.
- NEMO对ATM/IKKα的向有助于结直肠癌的化疗耐药性.
- 这一途径代表了改善癌症治疗结果的潜在治疗目标.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


